{"name":"Fountain Biopharma Inc.","slug":"fountain-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"FB825, FB825-15D11, Anti-CemX","genericName":"FB825, FB825-15D11, Anti-CemX","slug":"fb825-fb825-15d11-anti-cemx","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"FB825, FB825-15D11, Anti-CemX","genericName":"FB825, FB825-15D11, Anti-CemX","slug":"fb825-fb825-15d11-anti-cemx","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxON3haaElHU09WM2UxVFAtWGQyRUtONkJKSURwc1E0bWVjVnRTVTRTVklWSFBiZURWLWgtQWhEcGFBNmZLM0FhTFFZeE5tWE90dnRVRzk2bVlVVFEzS3dtX3c5T3Y3allKd1E2UEhUbzJGdnk0SlR4Z2hsTkxHTy1XNTljamJJcnJ2WG5YVUd2RS1pWlE4aHp0WFR2TGU1WGcxa3Fabk0walIxdGZCXzg3amhpTkpJSm12ajR5akpkTVpuc1RaSUZKek1yZEc1WVFGWVkwSnZBX1Q2T0EtUmlaREM4eVl4T3RoRE1iZmpkTTk0VUM2NXRhdkdxc3ZNOEJMTVc3Zk5HcUp0bzdESU42OFN0cmQ1ZDFYX0JzdVZBV0gtZjY0cDQzUl9sQ01fSllFcjhhRA?oc=5","date":"2025-07-10","type":"trial","source":"globenewswire.com","summary":"Interleukin-2 Inhibitors Clinical Trial Pipeline - globenewswire.com","headline":"Interleukin-2 Inhibitors Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQUlBEN2JQMkVlejVsUDE0d0pQcXhDTHBHdE1nMmhzTVNERFBfTDkzWW83Yi1ZZEpBbHowUjA1S0VpNnJ2NXZnUHRJY09NUDVxZnp2WFNxc1I2Q0x3dTFldXhFNm5JUDR5MlA4a0tDeTUxYm5WYTZMVzZUczJHYjBHbDFFaDRiTDZTSlJNRzFnbHBjNUYwNkR3ejJGa3AweDlpeVdhdk5ucGJmSHctSTdHS3g5N2lMYU1fMDB3TlYtUlBScG4zYUI4bk5LQjVlaGt3blZ5OWRfdkVCY2NFcWYtZ1UxVGxrZWJtZExQSGxFYUN4c1ZSQWhaZkxhT1M1RXRudlNuRXNlMXQ3MzFPMkZTeFRvS3VVaHprWlpsazd1akZOUQ?oc=5","date":"2024-11-06","type":"trial","source":"PR Newswire","summary":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOdlhsdGZaN3Frc1BrU21CeFpJNUEtbjNLcjNucXhJNkZ0RGNpdmpFem40RUpoRG9xU09reWZrOHpRT1h6RUZ0VmJNRFFRMDJITThnbzAxWU82ODJHTmlqV0hNVFk1LTdKVnd5NXQyT3ozVk55TS1YNWtwbGJlZFNUVlA5WFZFTDBSTndRS0lkYjlFU19BMVZ6dERpblBMZHFFTWtrVWtR?oc=5","date":"2024-05-28","type":"patent","source":"BioWorld News","summary":"Celltrion’s Omlyclo gets nod as Europe’s first Xolair biosimilar - BioWorld News","headline":"Celltrion’s Omlyclo gets nod as Europe’s first Xolair biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1XMTN6NlR1SG0xa1JSejhtdHp1cEFsQXpLc0pFeDZ5bHM4N1piMmJXaldUOTN1OU1xVXk1c0NfT1JLLWlmaWVxVF9jOHRzdnNHWHlqLXpWQjZ3dEhEM1pOZ0lYQnYtSExXSGc5Tl9iSG94b0hwRlBENm8zbEIyT1k?oc=5","date":"2023-02-22","type":"pipeline","source":"Pharma Voice","summary":"Tapping into the molecular fountain of youth - Pharma Voice","headline":"Tapping into the molecular fountain of youth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPNHIyTDJ4R013cFNZeGRuSzNEUjl0aVlLUzYzM3hNMmNIUE4wTkRseV9abXcyNW1oNnVnVGp3R3NKcnp1d3dhd0piTXhCTmZ3WHNtcXQ4dVVJaWI3MXhFRUxiMzExaGhZQzFaWi1NZ1N0ZXU4M1FVNUp0R3NMQ1M2UkJVc0Z3dTByS3VBUVRn?oc=5","date":"2021-09-16","type":"pipeline","source":"Pharmaceutical Technology","summary":"Billionaires are betting on Anti-Ageing Research, but can ageing really be cured? - Pharmaceutical Technology","headline":"Billionaires are betting on Anti-Ageing Research, but can ageing really be cured?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE82cURCeHcxVlFZSWpNQkR0b1Y3MG9DenJEXzE0cEgxUmFpbHNGYTdEUmFQSXRhWGROcTN4Y1QyZzZwWUdVN2QtbzM5aGN0TE4tNXBnSHVDNXNBblRONHlKWXZabEQ5Z1N4UWxOWkVnYTRicVFQNXRVUA?oc=5","date":"2015-10-28","type":"pipeline","source":"Fierce Biotech","summary":"Top women in biopharma 2015 - Fierce Biotech","headline":"Top women in biopharma 2015","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}